SAN DIEGO--(BUSINESS WIRE)--Orexigen™ Therapeutics, Inc. (Nasdaq:OREX), a biopharmaceutical company focused on the treatment of central nervous system disorders, including obesity, today announced that the Company will be presenting at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference. The conference is being held at the Grand Hyatt hotel in New York City. The Company is scheduled to present Wednesday, February 6 at 4:00 p.m. Eastern Time in Ballroom A.
